Clinical Trial Update: A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study compares the pharmacokinetics and safety of BR3005 given as a fixed-dose combination versus BR3005-1 and BR3005-2 given separately under fed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BR3005
• BR3005-1
• BR3005-2

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Type2 Diabetes Mellitus | Phase 1 | Status: COMPLETED